NYSE:PACSHealthcare
PACS Group (PACS): Valuation Check as Forbearance Extension Buys Time for Regulatory and Financial Progress
PACS Group (PACS) announced that it has secured an extension of its forbearance agreements with lenders, giving the company more time to address financial and regulatory hurdles. This move is closely connected to its efforts to regain NYSE compliance.
See our latest analysis for PACS Group.
PACS Group’s string of regulatory challenges and the recent forbearance extension come as the company’s share price continues to reflect uncertainty, with a 1-year total shareholder return of -37.07%...